<DOC>
	<DOCNO>NCT00877955</DOCNO>
	<brief_summary>This study test assumption bioavailability alprazolam new sublingual formulation sublingual formulation expect use commercially Brazil .</brief_summary>
	<brief_title>Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation</brief_title>
	<detailed_description />
	<mesh_term>Alprazolam</mesh_term>
	<criteria>Healthy male female subject BMI 17.5 30.5 Must provide inform consent Clinically significant disease Narrow angle glaucoma Positive drug screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>alprazolam</keyword>
	<keyword>sublingual</keyword>
</DOC>